300584 Nanjing Hicin Pharmaceutical
- 19.74
- +0.38+1.96%
Nanjing Hicin Pharmaceutical News
Nanjing Hicin Pharmaceutical: Announcement on the expiration and implementation of the plan for shareholding reduction by shareholders holding more than 5% of shares.
Nanjing Hicin Pharmaceutical: Announcement of shareholding reduction by shareholders who hold more than 5% of shares to less than 5% and notification of equity changes.
Nanjing Hicin Pharmaceutical: Simplified Equity Change Report
Nanjing Hicin Pharmaceutical: Announcement of the implementation of equity distribution in 2023.
Haichen Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Haichen Pharmaceutical: Pre-disclosure Notice on Shareholders Holding 5% or More of Their Shares Reducing Their Shareholding
Haichen Pharmaceutical: Announcement on the expiration of the plan for shareholders holding 5% or more of their shares to reduce their holdings by 1%
Haichen Pharmaceutical: Notice regarding partial share pledges and cancellation of pledges by controlling shareholders and actual controllers
Haichen Pharmaceutical: Pre-disclosure announcement on reduction of shareholders\' holdings by shareholders holding 5% or more
Haichen Pharmaceutical: Announcement on the company\'s controlling shareholders, actual controllers, and directors and supervisors pledge not to reduce their holdings of the company\'s shares
Haichen Pharmaceutical: Announcement on the cancellation of pledge of some shares of the company\'s controlling shareholder and actual controller
Haichen Pharmaceutical: Special explanation on the 2022 profit distribution plan
Haichen Pharmaceutical: Shareholder Dividend Return Plan for the Next Three Years (2023-2025)
Haichen Pharmaceutical: Haichen Pharmaceutical's announcement that the Shenzhen Stock Exchange agreed that the company withdrew the application documents for issuing shares to specific targets
Haichen Pharmaceutical: Notice on Termination of Issuance of Shares to Specific Targets and Withdrawal of Application Documents
Haichen Pharmaceutical: Announcement on the pledge and release of the pledge of some shares of the controlling shareholder and actual controller
Haichen Pharmaceutical: Prompt Notice on Responses to Audit Inquiries on Applications for Issuance of Shares to Specific Targets and Financial Data Updates for Application Documents such as Prospectus
Haichen Pharmaceutical: Verification and Analysis Report on Nanjing Haichen Pharmaceutical Co., Ltd.'s Plan to Issue A-Shares to Specific Targets (Revised Draft)
Haichen Pharmaceutical: Nanjing Haichen Pharmaceutical Co., Ltd. issues stock prospectus to specific targets (revised draft)
Haichen Pharmaceutical: Nanjing Haichen Pharmaceutical Co., Ltd.'s Plan to Issue A-Shares to Specific Targets (Revised Draft)
Analysis
Price Target
No Data
